{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:19Z","timestamp":1792757179690,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["UH2AR067677"],"award-info":[{"award-number":["UH2AR067677"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR063759"],"award-info":[{"award-number":["R01AR063759"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["UH2AR067691"],"award-info":[{"award-number":["UH2AR067691"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U01HG009379"],"award-info":[{"award-number":["U01HG009379"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI148435"],"award-info":[{"award-number":["R01AI148435"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunosuppressive and anti-cytokine treatment may have a protective effect for patients with COVID-19. Understanding the immune cell states shared between COVID-19 and other inflammatory diseases with established therapies may help nominate immunomodulatory therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To identify cellular phenotypes that may be shared across tissues affected by disparate inflammatory diseases, we developed a meta-analysis and integration pipeline that models and removes the effects of technology, tissue of origin, and donor that confound cell-type identification. Using this approach, we integrated &gt;\u2009300,000 single-cell transcriptomic profiles from COVID-19-affected lungs and tissues from healthy subjects and patients with five inflammatory diseases: rheumatoid arthritis (RA), Crohn\u2019s disease (CD), ulcerative colitis (UC), systemic lupus erythematosus (SLE), and interstitial lung disease. We tested the association of shared immune states with severe\/inflamed status compared to healthy control using mixed-effects modeling. To define environmental factors within these tissues that shape shared macrophage phenotypes, we stimulated human blood-derived macrophages with defined combinations of inflammatory factors, emphasizing in particular antiviral interferons IFN-beta (IFN-\u03b2) and IFN-gamma (IFN-\u03b3), and pro-inflammatory cytokines such as TNF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We built an immune cell reference consisting of &gt;\u2009300,000 single-cell profiles from 125 healthy or disease-affected donors from COVID-19 and five inflammatory diseases. We observed a\n                      <jats:italic>CXCL10+ CCL2+<\/jats:italic>\n                      inflammatory macrophage state that is shared and strikingly abundant in severe COVID-19 bronchoalveolar lavage samples, inflamed RA synovium, inflamed CD ileum, and UC colon. These cells exhibited a distinct arrangement of pro-inflammatory and interferon response genes, including elevated levels of\n                      <jats:italic>CXCL10<\/jats:italic>\n                      ,\n                      <jats:italic>CXCL9<\/jats:italic>\n                      ,\n                      <jats:italic>CCL2<\/jats:italic>\n                      ,\n                      <jats:italic>CCL3<\/jats:italic>\n                      ,\n                      <jats:italic>GBP1, STAT1<\/jats:italic>\n                      , and\n                      <jats:italic>IL1B<\/jats:italic>\n                      . Further, we found this macrophage phenotype is induced upon co-stimulation by IFN-\u03b3 and TNF-\u03b1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our integrative analysis identified immune cell states shared across inflamed tissues affected by inflammatory diseases and COVID-19. Our study supports a key role for IFN-\u03b3 together with TNF-\u03b1 in driving an abundant inflammatory macrophage phenotype in severe COVID-19-affected lungs, as well as inflamed RA synovium, CD ileum, and UC colon, which may be targeted by existing immunomodulatory therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-021-00881-3","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T13:49:28Z","timestamp":1618926568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":211,"title":["IFN-\u03b3 and TNF-\u03b1 drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation"],"prefix":"10.1186","volume":"13","author":[{"name":"Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA\/SLE) Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorien","family":"Shakib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica I.","family":"Beynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shanaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Korsunsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura T.","family":"Donlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1901-8265","authenticated-orcid":false,"given":"Soumya","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"issue":"23","key":"881_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319. https:\/\/doi.org\/10.1056\/NEJMra1004965.","journal-title":"N Engl J Med"},{"issue":"5","key":"881_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329\u201342. https:\/\/doi.org\/10.1038\/nri3661.","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"881_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jmv.25709","volume":"92","author":"J Liu","year":"2020","unstructured":"Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020;92(5):491\u20134. https:\/\/doi.org\/10.1002\/jmv.25709.","journal-title":"J Med Virol"},{"issue":"6","key":"881_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Cheng L, Li J, Wang X, Wang F, Liu L, Amit I, Zhang S, Zhang Z. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26(6):842\u20134. https:\/\/doi.org\/10.1038\/s41591-020-0901-9.","journal-title":"Nat Med"},{"issue":"1","key":"881_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen W, Su W, Tang H, le W, Zhang X, Zheng Y, Liu X, Xie L, Li J, Ye J, Dong L, Cui X, Miao Y, Wang D, Dong J, Xiao C, Chen W, Wang H. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6(1):31. https:\/\/doi.org\/10.1038\/s41421-020-0168-9.","journal-title":"Cell Discov"},{"issue":"10223","key":"881_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"issue":"7821","key":"881_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2588-y.","journal-title":"Nature"},{"key":"881_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","volume":"165-166","author":"W He","year":"2019","unstructured":"He W, Kapate N, Shields CW 4th, Mitragotri S. Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases. Adv Drug Deliv Rev. 2019;165-166:15\u201340. https:\/\/doi.org\/10.1016\/j.addr.2019.12.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"881_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/ar86","volume":"2","author":"RW Kinne","year":"2000","unstructured":"Kinne RW, Br\u00e4uer R, Stuhlm\u00fcller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2(3):189\u2013202. https:\/\/doi.org\/10.1186\/ar86.","journal-title":"Arthritis Res"},{"key":"881_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","volume":"10","author":"W-T Ma","year":"2019","unstructured":"Ma W-T, Gao F, Gu K, Chen D-K. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 2019;10:1140. https:\/\/doi.org\/10.3389\/fimmu.2019.01140.","journal-title":"Front Immunol"},{"issue":"2","key":"881_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, de Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274\u201388. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.006.","journal-title":"Immunity"},{"issue":"1","key":"881_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35\u201345. https:\/\/doi.org\/10.1038\/nri.2017.76.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"881_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20(7):928\u201342. https:\/\/doi.org\/10.1038\/s41590-019-0378-1.","journal-title":"Nat Immunol"},{"issue":"491","key":"881_CR14","doi-asserted-by":"publisher","first-page":"eaau8587","DOI":"10.1126\/scitranslmed.aau8587","volume":"11","author":"D Kuo","year":"2019","unstructured":"Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, Rozo C, Sokhi UK, Shanaj S, Oliver DJ, Echeverria AP, DiCarlo EF, Brenner MB, Bykerk VP, Goodman SM, Raychaudhuri S, R\u00e4tsch G, Ivashkiv LB, Donlin LT. HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11(491):eaau8587. https:\/\/doi.org\/10.1126\/scitranslmed.aau8587.","journal-title":"Sci Transl Med"},{"key":"881_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie CS, et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell. 2019;178:714\u2013730.e22.","journal-title":"Cell"},{"issue":"12","key":"881_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"issue":"5","key":"881_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","volume":"20","author":"T Stuart","year":"2019","unstructured":"Stuart T, Satija R. Integrative single-cell analysis. Nat Rev Genet. 2019;20(5):257\u201372. https:\/\/doi.org\/10.1038\/s41576-019-0093-7.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"881_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-019-0113-3","volume":"37","author":"B Hie","year":"2019","unstructured":"Hie B, Bryson B, Berger B. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama. Nat Biotechnol. 2019;37(6):685\u201391. https:\/\/doi.org\/10.1038\/s41587-019-0113-3.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"881_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi L, Lun ATL, Morgan MD, Marioni JC. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018;36(5):421\u20137. https:\/\/doi.org\/10.1038\/nbt.4091.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"881_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"881_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Pola\u0144ski","year":"2020","unstructured":"Pola\u0144ski K, Young MD, Miao Z, Meyer KB, Teichmann SA, Park JE. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics. 2020;36(3):964\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btz625.","journal-title":"Bioinformatics"},{"issue":"1","key":"881_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-019-1850-9","volume":"21","author":"HTN Tran","year":"2020","unstructured":"Tran HTN, Ang KS, Chevrier M, Zhang X, Lee NYS, Goh M, Chen J. A benchmark of batch-effect correction methods for single-cell RNA sequencing data. Genome Biol. 2020;21(1):12. https:\/\/doi.org\/10.1186\/s13059-019-1850-9.","journal-title":"Genome Biol"},{"issue":"9","key":"881_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545\u201358. https:\/\/doi.org\/10.1038\/s41577-018-0029-z.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"881_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574\u201383. https:\/\/doi.org\/10.1038\/s41590-019-0466-2.","journal-title":"Nat Immunol"},{"issue":"1","key":"881_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41467-017-02659-x","volume":"9","author":"W Stephenson","year":"2018","unstructured":"Stephenson W, Donlin LT, Butler A, Rozo C, Bracken B, Rashidfarrokhi A, Goodman SM, Ivashkiv LB, Bykerk VP, Orange DE, Darnell RB, Swerdlow HP, Satija R. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. Nat Commun. 2018;9(1):791. https:\/\/doi.org\/10.1038\/s41467-017-02659-x.","journal-title":"Nat Commun"},{"issue":"7","key":"881_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi A, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902\u201314. https:\/\/doi.org\/10.1038\/s41590-019-0398-x.","journal-title":"Nat Immunol"},{"key":"881_CR27","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"178","author":"JC Martin","year":"2019","unstructured":"Martin JC, et al. Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell. 2019;178:1493\u20131508.e20.","journal-title":"Cell"},{"issue":"12","key":"881_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2018","unstructured":"Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, Fernandez R, Akbarpour M, Chen CI, Ren Z, Verma R, Abdala-Valencia H, Nam K, Chi M, Han SH, Gonzalez-Gonzalez FJ, Soberanes S, Watanabe S, Williams KJN, Flozak AS, Nicholson TT, Morgan VK, Winter DR, Hinchcliff M, Hrusch CL, Guzy RD, Bonham CA, Sperling AI, Bag R, Hamanaka RB, Mutlu GM, Yeldandi AV, Marshall SA, Shilatifard A, Amaral LAN, Perlman H, Sznajder JI, Argento AC, Gillespie CT, Dematte J, Jain M, Singer BD, Ridge KM, Lam AP, Bharat A, Bhorade SM, Gottardi CJ, Budinger GRS, Misharin AV. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2018;199(12):1517\u201336. https:\/\/doi.org\/10.1164\/rccm.201712-2410OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7847","key":"881_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","volume":"590","author":"RA Grant","year":"2021","unstructured":"Grant RA, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590(7847):635\u201341. https:\/\/doi.org\/10.1038\/s41586-020-03148-w.","journal-title":"Nature"},{"issue":"5","key":"881_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34(5):525\u20137. https:\/\/doi.org\/10.1038\/nbt.3519.","journal-title":"Nat Biotechnol"},{"key":"881_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"881_CR32","doi-asserted-by":"crossref","unstructured":"Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. arXiv [physics.soc-ph]. 2008;(10):P10008.\u00a0https:\/\/arxiv.org\/abs\/0803.0476.","DOI":"10.1088\/1742-5468\/2008\/10\/P10008"},{"key":"881_CR33","doi-asserted-by":"crossref","unstructured":"McInnes L, Healy J, Melville J.\u00a0Umap: Uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv:1802.03426. 2018.\u00a0https:\/\/arxiv.org\/abs\/1802.03426.","DOI":"10.21105\/joss.00861"},{"issue":"12","key":"881_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"9","key":"881_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, Smibert P. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14(9):865\u20138. https:\/\/doi.org\/10.1038\/nmeth.4380.","journal-title":"Nat Methods"},{"issue":"463","key":"881_CR36","doi-asserted-by":"publisher","first-page":"eaaq0305","DOI":"10.1126\/scitranslmed.aaq0305","volume":"10","author":"CY Fonseka","year":"2018","unstructured":"Fonseka CY, Rao DA, Teslovich NC, Korsunsky I, Hannes SK, Slowikowski K, Gurish MF, Donlin LT, Lederer JA, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Todd DJ, Bykerk VP, Karlson EW, Ermann J, Lee YC, Brenner MB, Raychaudhuri S. Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis. Sci Transl Med. 2018;10(463):eaaq0305. https:\/\/doi.org\/10.1126\/scitranslmed.aaq0305.","journal-title":"Sci Transl Med"},{"issue":"6","key":"881_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"881_CR38","unstructured":"Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput. 2000:455\u201366.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/10902193\/."},{"key":"881_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036\u20131045.e9.","journal-title":"Cell"},{"issue":"1","key":"881_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.medj.2020.11.005","volume":"1","author":"PC Robinson","year":"2020","unstructured":"Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med. 2020;1(1):90\u2013102. https:\/\/doi.org\/10.1016\/j.medj.2020.11.005.","journal-title":"Med"},{"issue":"1","key":"881_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius M, Zheng S, Houck-Loomis B, Hao S, Yeung BZ, Mauck WM III, Smibert P, Satija R. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 2018;19(1):224. https:\/\/doi.org\/10.1186\/s13059-018-1603-1.","journal-title":"Genome Biol"},{"issue":"3","key":"881_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/cmi.2014.50","volume":"12","author":"A Dallagi","year":"2015","unstructured":"Dallagi A, Girouard J, Hamelin-Morrissette J, Dadzie R, Laurent L, Vaillancourt C, Lafond J, Carrier C, Reyes-Moreno C. The activating effect of IFN-\u03b3 on monocytes\/macrophages is regulated by the LIF-trophoblast-IL-10 axis via Stat1 inhibition and Stat3 activation. Cell Mol Immunol. 2015;12(3):326\u201341. https:\/\/doi.org\/10.1038\/cmi.2014.50.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"881_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","volume":"41","author":"W Luo","year":"2020","unstructured":"Luo W, Li YX, Jiang LJ, Chen Q, Wang T, Ye DW. Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19. Trends Pharmacol Sci. 2020;41(8):531\u201343. https:\/\/doi.org\/10.1016\/j.tips.2020.06.007.","journal-title":"Trends Pharmacol Sci"},{"key":"881_CR44","doi-asserted-by":"publisher","first-page":"101300","DOI":"10.1016\/j.smim.2019.101300","volume":"43","author":"BX Wang","year":"2019","unstructured":"Wang BX, Fish EN. Global virus outbreaks: Interferons as 1st responders. Semin Immunol. 2019;43:101300. https:\/\/doi.org\/10.1016\/j.smim.2019.101300.","journal-title":"Semin Immunol"},{"key":"881_CR45","doi-asserted-by":"crossref","unstructured":"Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS. Efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19: A randomized clinical trial. Antimicrobial Agents and Chemotherapy. 2020. https:\/\/aac.asm.org\/content\/64\/9\/e01061-20.","DOI":"10.1128\/AAC.01061-20"},{"key":"881_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","volume":"53","author":"SH Nile","year":"2020","unstructured":"Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66\u201370. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"881_CR47","first-page":"607","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `cytokine storm\u2019 in COVID-19. J Inf Secur. 2020;80:607\u201313.","journal-title":"J Inf Secur"},{"key":"881_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","volume":"146","author":"Y Cao","year":"2020","unstructured":"Cao Y, et al. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020;146:137\u2013146.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"881_CR49","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, Gitlin SD, Kaminski M, Cusick A, Phillips T, Sood S, Talpaz M, Quiery A, Boonstra PS, Wilcox RA. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019;6(12):e630\u20137. https:\/\/doi.org\/10.1016\/S2352-3026(19)30156-5.","journal-title":"Lancet Haematol"},{"issue":"12","key":"881_CR50","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1016\/S2665-9913(20)30340-4","volume":"2","author":"G Zizzo","year":"2020","unstructured":"Zizzo G, Cohen PL. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19? Lancet Rheumatol. 2020;2(12):e779\u201390. https:\/\/doi.org\/10.1016\/S2665-9913(20)30340-4.","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"881_CR51","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK. Baricitinib plus remdesivir for hospitalized adults with COVID-19. N Engl J Med. 2021;384(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa2031994.","journal-title":"N Engl J Med"},{"issue":"1","key":"881_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149\u201368.","journal-title":"Cell"},{"key":"881_CR53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran WF, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184:476\u2013488.e11.","journal-title":"Cell"},{"key":"881_CR54","doi-asserted-by":"crossref","unstructured":"Zhang F, Mears JR, Shakib L, Beynor JI, Shanaj S, Korsunsky I, Nathan A, Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA\/SLE) Consortium, Donlin LT, Raychaudhuri S. IFN-\u03b3 and TNF-\u03b1 drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. GSE168710, Gene Expression Omnibus, https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE168710 (2021).","DOI":"10.1101\/2020.08.05.238360"},{"key":"881_CR55","doi-asserted-by":"crossref","unstructured":"Zhang F, Mears JR, Shakib L, Beynor JI, Shanaj S, Korsunsky I, Nathan A, Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA\/SLE) Consortium, Donlin LT, Raychaudhuri S. IFN-\u03b3 and TNF-\u03b1 drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Github, https:\/\/github.com\/immunogenomics\/inflamedtissue_covid19_reference (2021).","DOI":"10.1101\/2020.08.05.238360"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-021-00881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-021-00881-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-021-00881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T13:51:21Z","timestamp":1618926681000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-021-00881-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1186\/s13073-021-00881-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.05.238360","asserted-by":"object"}]},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Healthy blood samples were purchased from the New York Blood Center (NYBC), provided by volunteer donors who consented for the blood to be used in biomedical research and other uses at the discretion of NYBC. The samples are deidentified by the NYBC, the research study investigators had no access to identifiable private information. As per the NIH guidelines, this does not constitute Human Subjects research. For the stimulated blood-derived macrophage experiment, co-cultures with synovial fibroblast involved synovial fibroblast lines generated from patients with RA undergoing arthroplasty (HSS IRB 14-033). Patients provided informed consent and all appropriate measures were taken for compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}